Are There Any Clinical Trials or Studies on G6PD Inhibitors?
Research on G6PD inhibitors is still in the early stages, with several preclinical studies showing promising results. Some compounds have progressed to clinical trials, focusing on their efficacy and safety in various cancer types. For instance, studies are exploring the use of G6PD inhibitors in hematological malignancies and solid tumors, either as monotherapy or in combination with other treatments.
